Watchman device to prevent stroke in atrial fibrillation
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a device called the WATCHMAN Elite, which is placed in a small pouch of the heart to close it and reduce stroke risk, potentially allowing patients to stop blood thinners. It is for people with atrial fibrillation who cannot or prefer not to take long-term blood thinners.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have atrial fibrillation that is not caused by heart valve problems.
- You have a moderate to high risk of stroke, based on your age and health conditions.
- You are willing to take blood thinners and antiplatelet medicines after the procedure.
- You have not had a stroke, heart attack, or major bleeding in the last 3 months.
- Your heart function is not severely reduced (ejection fraction is at least 30%).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests which blood-thinner approach works best after a procedure to close a small heart pouch (left atrial appendage) with a Watchman device. It aims to prevent strokes while reducing bleeding risks.
This trial tests a new medication to prevent strokes and blood clots in people with atrial fibrillation (an irregular heartbeat) who cannot safely take standard blood thinners. The drug works by blocking a different clotting factor, which may lower bleeding risks.
This study tests a new approach for people with atrial fibrillation (a type of irregular heartbeat) who are also at high risk for stroke. It combines a procedure to fix the heart's electrical signals with closing off a small pouch in the heart to reduce stroke risk, potentially avoiding long-term blood thinners.
This study uses a smartwatch to track your heart and look for changes in your atrial fibrillation (irregular heartbeat) over time. It aims to learn more about how the condition progresses and the risk of stroke or blood clots, which may help improve future care.
This trial tests the Zenith system, a device that seals off a heart area called the left atrial appendage to reduce stroke risk in people with atrial fibrillation (AF). You may be eligible if you have AF and a doctor recommends LAA closure, and you can return for follow-up scans and visits.
This trial compares a heart device that can help prevent blood clots in the heart (called LAAO) versus long-term blood thinners for people who have atrial fibrillation and recently had a stent placed. It aims to see which approach better prevents stroke and related blood-clot problems while keeping side effects manageable.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.